Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance.
- Second-quarter revenue grew 25% year-over-year to $871.3 million, on a reported basis, and 26% on an organic basis
- U.S. revenue rose 21%; international revenue increased 38% on a reported basis and 40% on an organic basis
- Operating income increased sharply to $128.1 million in Q2 from $77.0 million in the prior-year quarter
- Q2 net income was $115.9 million or $0.28 per share, compared to $50.9 million or $0.12 per share in the same quarter of 2022
- As of June 30, Dexcom held $3.64 billion in cash, cash equivalents, and marketable securities
- For fiscal 2023, the management expects total revenue to be in the range of $3.500 billion to 3.550 billion, which represents a 20-22% growth
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: How Deere & Company (DE) performed in Q2 2024
Deere & Company (NYSE: DE) reported second quarter 2024 earnings results today. Total net sales and revenues decreased 12% year-over-year to $15.2 billion. Net income was $2.37 billion, or $8.53
WMT Earnings: Key quarterly highlights from Walmart’s Q1 2025 financial results
Walmart Inc. (NYSE: WMT) reported its first quarter 2025 earnings results today. Consolidated revenue increased 6% year-over-year to $161.5 billion. Revenue growth on a constant currency basis was 5.8%. Consolidated
Home Depot (HD): A look at how the home improvement retailer fared in Q1 2024
Shares of Home Depot (NYSE: HD) rose over 2% on Wednesday. The stock has gained 19% over the past 12 months. The company delivered mixed results for the first quarter